TrialCardiovascular diabetology2025

Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial.

Artem Ovchinnikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.